Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

669
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
669
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

560
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
560
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.7K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The global need for paediatric palliative care: the evolution of serious health-related suffering in children aged 0-19 years from 1990 to 2023.

The Lancet. Child & adolescent health·2026
Same author

Response to Comment on the 2025 Global Map of Palliative Care: Data Clarity and Consistency (JPSM-D-25-01580).

Journal of pain and symptom management·2025
Same author

First-Ever Global Ranking of Palliative Care: 2025 World Map Under the New WHO Framework.

Journal of pain and symptom management·2025
Same author

Estimating the Number of Services & Patients Receiving Specialized Palliative Care Globally in 2025.

Journal of pain and symptom management·2025
Same author

The International Gynecologic Cancer Society consensus statement on palliative care.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2025
Same author

The evolution of serious health-related suffering from 1990 to 2021: an update to The Lancet Commission on global access to palliative care and pain relief.

The Lancet. Global health·2025

Related Experiment Video

Updated: Feb 24, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

701

Palliative Care for Tuberculosis.

Stephen R Connor1

  • 1Worldwide Hospice Palliative Care Alliance, Fairfax Station, Virginia, USA.

Journal of Pain and Symptom Management
|August 12, 2017
PubMed
Summary
This summary is machine-generated.

Palliative care (PC) integration for tuberculosis (TB) patients has progressed through training and guidelines. However, significant barriers like lack of awareness and resources hinder widespread PC education for TB professionals.

Keywords:
MDR-TBPalliative careTBWHO Stop TBWorldwide Hospice Palliative Care Alliancehospice

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K

Related Experiment Videos

Last Updated: Feb 24, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

701
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Palliative Care

Background:

  • Tuberculosis (TB) caused 1.5 million deaths globally in 2014, with 400,000 cases co-infected with HIV.
  • Drug-resistant TB strains present treatment challenges and higher failure rates.
  • Palliative care (PC) is crucial for managing suffering in incurable diseases.

Purpose of the Study:

  • To assess progress and remaining barriers in integrating palliative care (PC) for tuberculosis (TB) patients.
  • To evaluate a partnership aimed at enhancing TB professionals' ability to deliver PC.

Main Methods:

  • Development of a PC training curriculum for TB professionals.
  • Conducting training courses at major TB conferences (Union Lung Health).
  • Publication of findings and development of clinical guidelines.
  • Identification of model palliative care programs for TB.

Main Results:

  • A comprehensive PC training curriculum and clinical guidelines were developed.
  • Training courses were delivered, and publications produced over six years.
  • Significant barriers persist, including limited awareness and resource needs for PC education.

Conclusions:

  • Progress has been made in developing resources for palliative care in tuberculosis.
  • Substantial challenges remain in educating the TB and PC workforce.
  • Increased awareness and resources are vital to achieve the WHO's goal of zero suffering for TB patients.